A meta-analysis investigating the efficacy and safety of allergen-specific immunotherapy in the management of respiratory allergies

References

• Yacoub M-R, Incorvaia C, Caminati M, Colombo G. Immune mechanisms of allergen-specific immunotherapy. TOALLJ. 2012;5(1):47–52. doi:10.2174/1874838401205010047.
   Google Scholar
• James LK, Durham S. Update on mechanisms of allergen injection immunotherapy. Clin Exp Allergy. 2008;38(7):1074–1088. doi:10.1111/j.1365-2222.2008.02976.x.
   PubMed Web of Science ®Google Scholar
• Scadding G, Durham S. Mechanisms of sublingual immunotherapy. J Asthma. 2009;46(4):322–334. doi:10.1080/02770900902785729.
   PubMed Web of Science ®Google Scholar
• Noon L. Prophylactic inoculation against hay fever. Lancet. 1911;177(4580):1572–1573. doi:10.1016/S0140-6736(00)78276-6.
   Google Scholar
• Egger M, Smith GD, Phillips AN. Meta-analysis: principles and procedures. BMJ. 1997;315(7121):1533–1537. doi:10.1136/bmj.315.7121.1533.
   PubMed Web of Science ®Google Scholar
• Tramèr MR. CONSORT, QUOROM, and structured abstracts–new rules for authors, new tools for readers. Eur J Anaesthesiol. 2001;18(1):1–2.
   PubMed Web of Science ®Google Scholar
• Moher D, Cook DJ, Eastwood S, Olkin I, Rennie D, Stroup DF. Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Lancet. 1999;354(9193):1896–1900. doi:10.1016/s0140-6736(99)04149-5.
   PubMed Web of Science ®Google Scholar
• Calamita Z, Saconato H, Pelá AB, Atallah AN. Efficacy of sublingual immunotherapy in asthma: systematic review of randomized‐clinical trials using the Cochrane Collaboration method. Allergy. 2006;61(10):1162–1172. doi:10.1111/j.1398-9995.2006.01205.x.
   PubMed Web of Science ®Google Scholar
• Calderon MA, Carr VA, Jacobson M, Sheikh A, Durham S, Cochrane ENT Group Allergen injection immunotherapy for perennial allergic rhinitis. Cochrane Database Syst Rev. 2019;2019(1):99–110. doi:10.1002/14651858.CD007163.pub2.
   Google Scholar
• Chen L, Lei L, Cai Y, Li T. Specific sublingual immunotherapy in children with perennial rhinitis: a systemic review and meta‐analysis. Int Forum Allergy Rhinol. 2020;10(11):1226–1235. doi:10.1002/alr.22589.
   PubMed Web of Science ®Google Scholar
• Penagos M, Compalati E, Tarantini F, Baena-Cagnani R, Huerta J, Passalacqua G, Canonica GW. Efficacy of sublingual immunotherapy in the treatment of allergic rhinitis in pediatric patients 3 to 18 years of age: a meta-analysis of randomized, placebo-controlled, double-blind trials. Ann Allergy Asthma Immunol. 2006;97(2):141–148. doi:10.1016/S1081-1206(10)60004-X.
   PubMed Web of Science ®Google Scholar
• Dhami S, Kakourou A, Asamoah F, Agache I, Lau S, Jutel M, Muraro A, Roberts G, Akdis CA, Bonini M, et al. Allergen immunotherapy for allergic asthma: a systematic review and meta‐analysis. Allergy. 2017;72(12):1825–1848. doi:10.1111/all.13208.
   PubMed Web of Science ®Google Scholar
• Di Bona D, Plaia A, Leto-Barone MS, La Piana S, Di Lorenzo G. Efficacy of subcutaneous and sublingual immunotherapy with grass allergens for seasonal allergic rhinitis: a meta-analysis–based comparison. J Allergy Clin Immunol. 2012;130(5):1097–1107. e2. doi:10.1016/j.jaci.2012.08.012.
   PubMed Web of Science ®Google Scholar
• Dranitsaris G, Ellis AK. Sublingual or subcutaneous immunotherapy for seasonal allergic rhinitis: an indirect analysis of efficacy, safety and cost. J Eval Clin Pract. 2014;20(3):225–238. doi:10.1111/jep.12112.
   PubMed Web of Science ®Google Scholar
• Feng B, Wu J, Chen B, Xiang H, Chen R, Li B, Chen S. Efficacy and safety of sublingual immunotherapy for allergic rhinitis in pediatric patients: a meta-analysis of randomized controlled trials. Am J Rhinol Allergy. 2017;31(1):27–35. doi:10.2500/ajra.2017.31.4382.
   PubMed Web of Science ®Google Scholar
• Feng S, Xu Y, Ma R, Sun Y, Luo X, Li H. Cluster subcutaneous allergen specific immunotherapy for the treatment of allergic rhinitis: a systematic review and meta-analysis. PLoS One. 2014;9(1):e86529. doi:10.1371/journal.pone.0086529.
   PubMed Web of Science ®Google Scholar
• Li Y, Yu S-Y, Tang R, Zhao Z-T, Sun J-L. Sublingual immunotherapy tablets relieve symptoms in adults with allergic rhinitis: a meta-analysis of randomized clinical trials. Chin Med J (Engl). 2018;131(21):2583–2588. doi:10.4103/0366-6999.244108.
   PubMed Web of Science ®Google Scholar
• Liao W, Hu Q, Shen L-L, Hu Y, Tao H-F, Li H-F, Fan W-T. Sublingual immunotherapy for asthmatic children sensitized to house dust mite: a meta-analysis. Medicine (Baltimore). 2015;94(24):e701. doi:10.1097/MD.0000000000000701.
   PubMed Web of Science ®Google Scholar
• Yang L, Zhu R. Immunotherapy of house dust mite allergy. Hum Vaccin Immunother. 2017;13(10):2390–2396. doi:10.1080/21645515.2017.1364823.
   PubMed Web of Science ®Google Scholar
• Fortescue R, Kew KM, Leung MST. Sublingual immunotherapy for asthma. Cochrane Database Syst Rev. 2015;8(9):CD011293. doi:10.1002/14651858.CD011293.pub2.
   Google Scholar
• Radulovic S, Calderon MA, Wilson D, Durham S, Group CE, Cochrane ENT Group Sublingual immunotherapy for allergic rhinitis. Cochrane Database Syst Rev. 2010;2011(2):1105–1110. doi:10.1002/14651858.CD002893.pub2.
   Google Scholar
• Tao L, Shi B, Shi G, Wan H. Efficacy of sublingual immunotherapy for allergic asthma: retrospective meta‐analysis of randomized, double‐blind and placebo‐controlled trials. Clin Respir J. 2014;8(2):192–205. doi:10.1111/crj.12058.
   PubMed Web of Science ®Google Scholar
• Tie K, Miller C, Zanation AM, Ebert CSJr. Subcutaneous versus sublingual immunotherapy for adults with allergic rhinitis: a systematic review with meta‐analyses. Laryngoscope. 2022;132(3):499–508. doi:10.1002/lary.29586.
   PubMed Web of Science ®Google Scholar
• Wilson D, Torres Lima M, Durham S. Sublingual immunotherapy for allergic rhinitis: systematic review and meta‐analysis. Allergy. 2005;60(1):4–12. doi:10.1111/j.1398-9995.2005.00699.x.
   PubMed Web of Science ®Google Scholar
• Penagos M, Passalacqua G, Compalati E, Baena-Cagnani CE, Orozco S, Pedroza A, Canonica GW. Metaanalysis of the efficacy of sublingual immunotherapy in the treatment of allergic asthma in pediatric patients, 3 to 18 years of age. Chest. 2008;133(3):599–609. doi:10.1378/chest.06-1425.
   PubMed Web of Science ®Google Scholar
• Abramson MJ, Puy RM, Weiner JM. Injection allergen immunotherapy for asthma. Cochrane Database Syst Rev. 2010;(8;(8):CD001186. doi:10.1002/14651858.CD001186.pub2.
   PubMed Web of Science ®Google Scholar
• Olaguíbel JM, Alvarez Puebla MJ. Efficacy of sublingual allergen vaccination for respiratory allergy in children. Conclusions from one meta-analysis. J Investig Allergol Clin Immunol. 2005;15(1):9–16.
   PubMed Web of Science ®Google Scholar
• Werner MT, Bosso JV. Intralymphatic immunotherapy for allergic rhinitis: a systematic review and meta-analysis. Allergy Asthma Proc. 2021;42(4):283–292.
   Google Scholar
• Zhu W, Gao P, Zhang Q, Chen J. Efficacy and safety of subcutaneous immunotherapy for local allergic rhinitis: a meta-analysis of randomized controlled trials. Am J Rhinol Allergy. 2022;36(2):245–252. doi:10.1177/19458924211050547.
   PubMed Web of Science ®Google Scholar
• Hoang MP, Seresirikachorn K, Chitsuthipakorn W, Snidvongs K. Intralymphatic immunotherapy for allergic rhinoconjunctivitis: a systematic review and meta-analysis. Rhinology. 2021;59(3):236–244. doi:10.4193/Rhin20.572.
   PubMed Web of Science ®Google Scholar
• Aini NR, Mohd Noor N, Md Daud MK, Wise SK, Abdullah B. Efficacy and safety of intralymphatic immunotherapy in allergic rhinitis: a systematic review and meta‐analysis. Clin Transl Allergy. 2021;11(6):e12055. doi:10.1002/clt2.12055.
   PubMed Web of Science ®Google Scholar
• Scadding GK. Grand challenges in rhinology. Front Allergy. 2020;1:584518. doi:10.3389/falgy.2020.584518.
   PubMedGoogle Scholar
• Scadding GK, Hellings PW, Bachert C, Bjermer L, Diamant Z, Gevaert P, Kjeldsen A, Kleine-Tebbe J, Klimek L, Muraro A, et al. Allergic respiratory disease care in the COVID-19 era: a EUFOREA statement. World Allergy Organ J. 2020;13(5):100124.
   PubMed Web of Science ®Google Scholar
• Sedaghat AR, Kuan EC, Scadding GK. Epidemiology of chronic rhinosinusitis: prevalence and risk factors. J Allergy Clin Immunol Pract. 2022;10(6):1395–1403. doi:10.1016/j.jaip.2022.01.016.
   PubMed Web of Science ®Google Scholar
• Passalacqua G, Durham SR, Global Allergy and Asthma European Network Allergic rhinitis and its impact on asthma update: allergen immunotherapy. J Allergy Clin Immunol. 2007;119(4):881–891. doi:10.1016/j.jaci.2007.01.045.
   PubMed Web of Science ®Google Scholar
• Nelson HS. Allergen immunotherapy: where is it now? J Allergy Clin Immunol. 2007;119(4):769–779. doi:10.1016/j.jaci.2007.01.036.
   PubMed Web of Science ®Google Scholar
• Larenas-Linnemann D, Cox LS. Sublingual immunotherapy for asthma: need for high quality meta-analyses to prove the concept. Allergy. 2007;62(6):704–705. doi:10.1111/j.1398-9995.2007.01335.x.
   PubMed Web of Science ®Google Scholar
• Sopo SM, Macchiaiolo M, Zorzi G, Tripodi S. Sublingual immunotherapy in asthma and rhinoconjunctivitis; systematic review of paediatric literature. Arch Dis Child. 2004;89(7):620–624. doi:10.1136/adc.2003.030411.
   PubMed Web of Science ®Google Scholar
• Nagata M, Nakagome K. Allergen immunotherapy in asthma: current status and future perspectives. Allergol Int. 2010;59(1):15–19. doi:10.2332/allergolint.09-RAI-0150.
   PubMedGoogle Scholar
• Calderón MA, Casale TB, Togias A, Bousquet J, Durham SR, Demoly P. Allergen-specific immunotherapy for respiratory allergies: from meta-analysis to registration and beyond. J Allergy Clin Immunol. 2011;127(1):30–38. doi:10.1016/j.jaci.2010.08.024.
   PubMed Web of Science ®Google Scholar
• Novakova P, Tiotiu A, Baiardini I, Krusheva B, Chong-Neto H, Novakova S. Allergen immunotherapy in asthma: current evidence. J Asthma. 2021;58(2):223–230. doi:10.1080/02770903.2019.1684517.
   PubMed Web of Science ®Google Scholar